Trump Treated With Experimental Mixture Of COVID-19 Antibodies

JAKARTA - President Donald Trump "still feels tired but excited" after being given the experimental COVID-19 antibody mixture treatment. That was said by Dr. Sean Conley as the president's doctor in a statement quoted by Reuters, Friday, October 2.

Reporting from Antara, Saturday, October 3, Conley said, Trump received a double dose of Regeneron Pharmaceuticals antibodies intravenously, and also took zinc supplements, vitamin D, famotidine, melatonin and aspirin.

The Regeneron drug, REGN-COV2, is part of an experimental class of COVID-19 drugs known as monoclonal antibodies, which are artificial copies of human antibodies to the virus that are being studied for use in patients with early disease.

This technique has been used widely to treat various diseases. So far, data for COVID-19 antibodies are limited but the head of the US Centers for Disease Control and Prevention (CDC), Dr. Anthony Fauci, also mentioned that the technique is promising.

Regeneron this week reported the results of clinical trials proving that his antibody drug appears to treat symptoms in outpatients with COVID-19, without serious side effects.

Regeneron also said he plans to discuss authorizing emergency use of the antibodies with the US Food and Drug Administration (FDA)